BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 17403076)

  • 1. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
    Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
    Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.
    Kawano S; Okada H; Kawahara Y; Hori K; Tanioka D; Tsuzuki T; Inoue M; Yagi S; Takenaka R; Yamamoto K
    Digestion; 2011; 84(1):46-53. PubMed ID: 21304241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
    Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
    Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antisecretory agents for gastric endoscopic submucosal dissection.
    Fujishiro M; Chiu PW; Wang HP
    Dig Endosc; 2013 Mar; 25 Suppl 1():86-93. PubMed ID: 23368844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
    Ono S; Kato M; Ono Y; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
    Endoscopy; 2009 Apr; 41(4):299-303. PubMed ID: 19340731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
    Yang Z; Wu Q; Liu Z; Wu K; Fan D
    Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial.
    Lee JY; Jang JS
    Arab J Gastroenterol; 2021 Jun; 22(2):115-120. PubMed ID: 33551349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
    Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
    Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
    Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
    Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms?
    Lim JH; Kim SG; Kim JW; Choi YJ; Kwon J; Kim JY; Lee YB; Choi J; Im JP; Kim JS; Jung HC; Song IS
    Gastrointest Endosc; 2012 Apr; 75(4):719-27. PubMed ID: 22317881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
    Andriulli A; Annese V; Caruso N; Pilotto A; Accadia L; Niro AG; Quitadamo M; Merla A; Fiorella S; Leandro G
    Am J Gastroenterol; 2005 Jan; 100(1):207-19. PubMed ID: 15654802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison on Oral versus Intravenous Proton Pump Inhibitors for Prevention of Bleeding after Endoscopic Submucosal Dissection of Gastric Lesions].
    Jung YS; Kim KO; Lee SH; Jang BI; Kim TN
    Korean J Gastroenterol; 2016 Feb; 67(2):74-80. PubMed ID: 26907482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.
    Jeong HK; Park CH; Jun CH; Lee GH; Kim HI; Kim HS; Choi SK; Rew JS
    J Korean Med Sci; 2007 Dec; 22(6):1055-9. PubMed ID: 18162722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.